SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
65 hedge funds and large institutions have $218M invested in Syros Pharmaceuticals, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-3
Holders Change %
-4.41%
% of All Funds
1.41%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
24
Reduced
23
Closed
10
Calls
$247K
Puts
–
Net Calls
+$247K
Net Calls Change
+$162K